INVO Fertility, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
INVO Fertility, Inc. (IVF) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$238.54 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2022-11-14
- INVO Fertility, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-09-30 was -$238.54K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month |
|---|---|---|
| 2021-09-30 | -$238.54K 10-Q · filed 2022-11-14 | -$238.54K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |